DATA GRAPHICS | Data Byte
Colitis innovation in the Distillery spotlight
Targets include LRH-1, PYK2, BDNF, HSF1, ZDHHC7, LYPLA2 and cGas
April 20, 2022 11:04 PM UTC
Recent colitis innovations captured in BioCentury’s Distillery span targets that could treat several forms of the disease, including ulcerative colitis, enterocolitis and colitis-associated colorectal cancer.
BioCentury’s Distillery, a curated collection of translational studies from over 25 journals, provides summaries of preclinical papers that showcase targets and technologies with disease-modifying effects...